CY1112195T1 - Μεθοδος παρασκευης ενος πεπτιδιου με pl πανω απο 8 ή κατω απο 5 - Google Patents

Μεθοδος παρασκευης ενος πεπτιδιου με pl πανω απο 8 ή κατω απο 5

Info

Publication number
CY1112195T1
CY1112195T1 CY20111101251T CY111101251T CY1112195T1 CY 1112195 T1 CY1112195 T1 CY 1112195T1 CY 20111101251 T CY20111101251 T CY 20111101251T CY 111101251 T CY111101251 T CY 111101251T CY 1112195 T1 CY1112195 T1 CY 1112195T1
Authority
CY
Cyprus
Prior art keywords
peptide
preparing
fusion
acid cleavage
partner
Prior art date
Application number
CY20111101251T
Other languages
English (en)
Inventor
N Stephen Pollitt
Douglas I Buckley
Peter A Stathis
Taymar E Hartman
Ziyang Zhong
Original Assignee
Scios Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scios Inc. filed Critical Scios Inc.
Publication of CY1112195T1 publication Critical patent/CY1112195T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/12—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by hydrolysis, i.e. solvolysis in general
    • C07K1/122—Hydrolysis with acids different from HF
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • C12N9/1033—Chloramphenicol O-acetyltransferase (2.3.1.28)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y203/00—Acyltransferases (2.3)
    • C12Y203/01—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • C12Y203/01028—Chloramphenicol O-acetyltransferase (2.3.1.28)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Small-Scale Networks (AREA)

Abstract

Περιγράφεται μέθοδος παρασκευής ενός πεπτιδίου που έχει pl πάνω από 8 ή κάτω από 5, όπου το πεπτίδιο εκφράζεται σαν πρωτεΐνη σύντηξης, στην οποία είναι συνδεδεμένο προς έναν συνεργάτη σύντηξης μέσω μιας θέσης διάσπασης οξέος. Το πεπτίδιο απελευθερώνεται από τον συνεργάτη σύντηξη με διάσπαση οξέος απουσία χαοτρόπου. Ο συνεργάτης σύντηξης και τα προϊόντα διάσπασης οξέος, αυτού, εάν υπάρχουν, έχουν ένα καθαρό φορτίο επαρκώς διαφορετικό από εκείνο του επιθυμητού πεπτιδίου για να επιτρέπεται απομόνωση του πεπτιδίου με χρωματογραφία ιονο-εναλλαγής.
CY20111101251T 1998-07-10 2011-12-16 Μεθοδος παρασκευης ενος πεπτιδιου με pl πανω απο 8 ή κατω απο 5 CY1112195T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9242398P 1998-07-10 1998-07-10
EP06008034A EP1714972B1 (en) 1998-07-10 1999-07-08 Method for producing a peptide with a pl above 8 or below 5

Publications (1)

Publication Number Publication Date
CY1112195T1 true CY1112195T1 (el) 2015-12-09

Family

ID=22233139

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20061100896T CY1106110T1 (el) 1998-07-10 2006-06-30 ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΕΝΟΣ ΠΕΠΤΙΔΙΟΥ ΜΕ pI ΠΑΝΩ ΑΠΟ 8 Ή ΚΑΤΩ ΑΠΟ 5
CY20111101251T CY1112195T1 (el) 1998-07-10 2011-12-16 Μεθοδος παρασκευης ενος πεπτιδιου με pl πανω απο 8 ή κατω απο 5

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY20061100896T CY1106110T1 (el) 1998-07-10 2006-06-30 ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΕΝΟΣ ΠΕΠΤΙΔΙΟΥ ΜΕ pI ΠΑΝΩ ΑΠΟ 8 Ή ΚΑΤΩ ΑΠΟ 5

Country Status (14)

Country Link
US (1) US6303340B1 (el)
EP (3) EP2305815B1 (el)
JP (2) JP4741076B2 (el)
CN (2) CN1242062C (el)
AT (2) ATE529515T1 (el)
AU (1) AU4859599A (el)
CA (1) CA2334160C (el)
CY (2) CY1106110T1 (el)
DE (1) DE69930938T2 (el)
DK (2) DK1095141T3 (el)
ES (2) ES2374829T3 (el)
HK (2) HK1036637A1 (el)
PT (2) PT1095141E (el)
WO (1) WO2000003011A2 (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1196094A (zh) * 1995-09-07 1998-10-14 诺沃挪第克公司 除垢剂酶活性的噬菌体显示
AU2002314111A1 (en) 2001-06-15 2003-01-02 F. Hoffmann-La Roche Ag Method for the recombinant production of peptidic antiviral fusion inhibitors, and acetylation of gb41 fragments
CN100427506C (zh) 2001-07-26 2008-10-22 高级蛋白质技术公司 从融合多肽制备感兴趣的多肽的方法
WO2006041945A2 (en) * 2004-10-04 2006-04-20 Novetide, Ltd. A counterion exchange process for peptides
JP2008054673A (ja) * 2006-08-03 2008-03-13 Hokkaido Univ 組み換え蛋白質の製造方法
US8951185B2 (en) 2007-10-26 2015-02-10 Ams Research Corporation Surgical articles and methods for treating pelvic conditions
US20090035815A1 (en) * 2007-06-29 2009-02-05 Laxmi Srinivas Rao Synthetic Gene for Enhanced Expression in E. Coli
US8609621B2 (en) 2010-11-15 2013-12-17 E I Du Pont De Nemours And Company Acid-cleavable linkers exhibiting altered rates of acid hydrolysis
CN107266554A (zh) * 2012-03-19 2017-10-20 麦德林制药私人有限公司 制备重组血管扩张肽的方法、表达构建体、宿主细胞及重组融合多肽
US20150099860A1 (en) * 2013-10-08 2015-04-09 Proteins Easy Corp Methods for separating and purifying endogenous, exogenous and recombinant proteins/peptides from plants and animals using aqueous-free, anhydrous strategies
CN106928316B (zh) * 2015-12-31 2020-11-20 深圳翰宇药业股份有限公司 一种纯化氧化含二硫键多肽的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8314362D0 (en) * 1983-05-24 1983-06-29 Celltech Ltd Polypeptide and protein products
DK175535B1 (da) * 1987-03-04 2004-11-29 Daiichi Suntory Pharma Co Ltd Fremgangsmåde til fremstilling af et fysiologisk aktivt cysteinholdigt peptid
US5114923A (en) * 1988-05-31 1992-05-19 California Biotechnology Inc. Recombinant techniques for production of novel natriuretic and vasodilator peptides
EP0428615A4 (en) * 1988-08-11 1991-11-13 California Biotechnology, Inc. Method for stabilizing heterologous protein expression and vectors for use therein
US5595887A (en) * 1990-07-16 1997-01-21 Bionebraska, Inc. Purification directed cloning of peptides using carbonic anhydrase as the affinity binding segment
US5202239A (en) * 1990-08-07 1993-04-13 Scios Nova Inc. Expression of recombinant polypeptides with improved purification
AU664030B2 (en) * 1991-02-27 1995-11-02 Micromet Ag Serine-rich peptide linkers
ATE253639T1 (de) * 1991-08-19 2003-11-15 Daiichi Suntory Pharma Co Ltd Verfahren zur herstellung von peptiden
JP3531947B2 (ja) * 1991-08-19 2004-05-31 第一サントリーファーマ株式会社 ペプチドの製造方法
US5589364A (en) 1994-07-29 1996-12-31 Magainin Pharmaceuticals Inc. Recombinant production of biologically active peptides and proteins
JP3995279B2 (ja) * 1994-09-07 2007-10-24 アスビオファーマ株式会社 蛋白の製造方法
CA2198966C (en) * 1996-03-04 2011-06-21 Yuji Suzuki Method for cleaving chimeric protein using processing enzyme
US5851802A (en) * 1996-03-22 1998-12-22 Xoma Corporation Methods for recombinant microbial production of fusion proteins and BPI-derived peptides

Also Published As

Publication number Publication date
EP2305815B1 (en) 2014-11-05
CY1106110T1 (el) 2011-06-08
DK1714972T3 (da) 2012-01-23
CN1521261A (zh) 2004-08-18
ES2263278T3 (es) 2006-12-01
EP1714972B1 (en) 2011-10-19
JP2002520018A (ja) 2002-07-09
DK1095141T3 (da) 2006-07-31
ATE529515T1 (de) 2011-11-15
JP5291137B2 (ja) 2013-09-18
DE69930938T2 (de) 2007-01-11
AU4859599A (en) 2000-02-01
EP1714972A2 (en) 2006-10-25
CA2334160C (en) 2016-09-27
HK1036637A1 (en) 2002-01-11
DE69930938D1 (de) 2006-05-24
WO2000003011A3 (en) 2000-06-15
ES2374829T3 (es) 2012-02-22
CN1242062C (zh) 2006-02-15
JP2011172575A (ja) 2011-09-08
EP2305815A1 (en) 2011-04-06
CA2334160A1 (en) 2000-01-20
WO2000003011A2 (en) 2000-01-20
PT1095141E (pt) 2006-07-31
CN1170932C (zh) 2004-10-13
HK1097280A1 (en) 2007-06-22
CN1313896A (zh) 2001-09-19
EP1714972A3 (en) 2008-05-28
ATE323765T1 (de) 2006-05-15
PT1714972E (pt) 2011-12-26
EP1095141B1 (en) 2006-04-19
US6303340B1 (en) 2001-10-16
EP1095141A2 (en) 2001-05-02
JP4741076B2 (ja) 2011-08-03

Similar Documents

Publication Publication Date Title
CY1112195T1 (el) Μεθοδος παρασκευης ενος πεπτιδιου με pl πανω απο 8 ή κατω απο 5
CY1121353T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις
DE3885214D1 (de) Verfahren zur Isolierung basischer Proteine aus Proteingemischen.
EA200300137A1 (ru) Анти-il-12-антитела, композиции, способы и применения
ATE412432T1 (de) Internalisierende erbb2 antikörper
NO961115L (no) Humane metabotrope glutamatreseptorsubtyper (HMR4, HMR6, HMR7) og relaterte DNA forbindelser
CY1105895T1 (el) Χιμαιρικη πρωτεϊνη διαλυτου υποδοχεα/συνδετη ιντepλευκινης-6, αναλογα και αυτης και χρησεις αυτης
WO2002012501A3 (en) Anti-dual integrin antibodies, compositions, methods and uses
CA2263713A1 (en) Lyophilization of cultured human cells to preserve rna and dna
AR016436A1 (es) Proteina que inhibe a la p27, adn que la codifica, anticuerpos y productos de disociacion de los mismos, acido nucleico antisentido, estructura artificialde acido nucleico y la utilizacion de todo esto en terapia y profilaxis de enfermedades
ATE258598T1 (de) Verfahren zur proteinrückfaltung durch verwendung zwitterionischer wirkstoffe von niedrigem molekulargewicht
BR9809516A (pt) Proteìnas com atividades inseticidas e método de uso
TR199802394A3 (tr) Proteinleri stabilize etmek için gelistirilmis proses.
IL127297A0 (en) Spruce budworm antifreeze proteins genes and methods of using same
ES2141249T3 (es) Procedimiento para la identificacion de celulas humanas y animales que presentan la capacidad para una proliferacion ilimitada o para una formacion de tumores.
ATE285474T1 (de) Haemophilus adhäsionsproteinen
SE9602822D0 (sv) New receptor
NO940090D0 (no) Blanding for makrodefekt-fri sement, samt fremgangsmaate for frems tilling av denne
WO1998017827A3 (en) Compositions and methods using eukaryotic rad52
WO2001053339A3 (en) Egg specific surface proteins
CA2243578A1 (en) High affinity nucleic acid ligands of complement system proteins
SE9604439D0 (sv) New receptor
WO2003063767A3 (en) Rsv proteins, antibodies, compositions, methods and uses
DK0938555T3 (da) Konstruktioner og komplekser af cyclin E
AU4494599A (en) Method for genetic engineering of disease resistance using the drr206 class of proteins